Paper Review Records
All Paper Review Records
11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Cold atmospheric plasma affects metabolic processes in malignant melanoma
AuthorsErika Rein; Tom Zimmermann; Stefan Fischer; Zubeir El Ahmad; R. Verena Taudte; Arne Gessner; Martin F. Fromm; Melanie Kappelmann-Fenzl; Anja Bosserhoff
Affiliations1. Institute of Biochemistry, University of Erlangen-Nürnberg, Erlangen, Germany; 2. Faculty of Computer Science, Deggendorf Institute of Technology, Deggendorf, Germany; 3. Institute of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nürnberg, Erlangen, Germany; 4. FAU NeW - Research Center New Bioactive Compounds, University of Erlangen-Nürnberg, Erlangen, Germany; 5. Comprehensive Cancer Center Erlangen-EMN (CCC ER- EMN), Erlangen, Germany; 6. Comprehensive Cancer Center Alliance WERA (CCC WERA), Erlangen, Germany; 7. Bavarian Cancer Research Center (BZKF), Erlangen, Germany
NPTXR as a novel therapeutic target: efficacy of antibody-drug conjugates in preclinical tumor models
AuthorsMykola Lyndin; Michel Janicot; Justus Müller; Peter Schiemann; Gunther Wennemuth
Affiliations1. Department of Anatomy, University of Duisburg-Essen, Medical Faculty, Essen, Germany; 2. Ymmunobio AG, Riehen, Switzerland
Quantifying target antigen-dependent CAR T-cell performance against AML
AuthorsSaumil Shah; Jan Mueller; Emanuel Vogel; Michael Raatz; Steffen Boettcher; Arne Traulsen; Markus G. Manz; Philipp M. Altrock
Affiliations1. Department of Theoretical Biology, Max Planck Institute for Evolutionary Biology, Plön, Germany; 2. Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland; 3. Department of Internal Medicine V, Hematology & Oncology, Medical University of Innsbruck, Innsbruck, Austria; 4. Department of Hematology and Oncology, Kiel University and University Hospital Schleswig-Holstein, Kiel, Germany; 5. Clinical Research Unit CATCH ALL (KFO 5010), Kiel, Germany
The oral microbiota in oral squamous cell carcinoma: unravelling mechanisms and clinical potential
AuthorsAmany Hany Mohamed Kamel; Nourhan El-Tantawy; Sarah Ahmed; Al-Hassan Soliman Wadan; Nermeen AbuBakr
Affiliations1. Oral Biology Department, Faculty of Dentistry, Cairo University, Cairo, Egypt; 2. Oral Biology Department, Faculty of Dentistry, Delta University, Mansoura, Egypt; 3. Ministry of Health and Population, Cairo, Egypt; 4. Oral Biology Department, Faculty of Dentistry, Galala University, Suez, Egypt
CAR-T and TIL therapies in solid tumors: barriers, clinical lessons, and convergent solutions
AuthorsDuc-Hiep Bach; Van T. Hoang; Thi Viet Pham; Huong; Dinh Duy Nguyen; Thanh Liem Nguyen
Affiliations1. Vinmec Research Institute of Stem Cell and Gene Technology, College of Health Sciences, Hanoi, Vietnam; 2. Vinmec International Hospital, Vinmec Health Care System, Hanoi, Vietnam
Integrative plasma-to-spatial proteomics reveals fibroblast-associated signatures in liver metastatic breast cancer
AuthorsElif Öcal; Janik Riese; Ursula Schneider; Mark P. Kühnel; Danny Jonigk; Heidrun Hirner-Eppeneder; Stefanie Corradini; Osman Öcal; S. Nahum Goldberg; Max Seidensticker; Jens Ricke; Moritz Wildgruber; Marianna Alunni-Fabbroni
Affiliations1. Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany; 2. Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; 3. Institute of Pathology, Aachen University Hospital, Aachen, Germany; 4. Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany; 5. Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; 6. Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany; 7. Department of Radiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
Macrophage-derived CTSZ promotes prostate cancer progression via αVβ3 integrin-mediated activation of the AKT/FOXO1/JUNB signaling axis
AuthorsYouxin Liu; Saipeng Chen; Jie Xu; Hang Yuan; Hanzi Yang; Bingqian Deng; Jie Feng; Heting Liu; Langlang Xie; Gang Huang; Wenhao Shen
Affiliations1. Department of Urology, Southwest Hospital, Army Medical University, Third Military Medical University, Chongqing, China; 2. Department of Urology, The 968th Hospital of Joint Logistics Support Force of PLA, Jinzhou, China; 3. Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Army Medical University, Third Military Medical University, Chongqing, China
Integrative analysis of SLFN11-related DEGs reveals novel biomarkers for cisplatin sensitivity and immune modulation in colorectal cancer
AuthorsWei Wang; Lijiang Zhou; Jing Wang; Tingting Li; Zheng Li
Affiliations1. Department of Integrated Chinese and Western medicine, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, China; 2. Department of Oncology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China; 3. Traditional Chinese medicine oncology, Liaoning University of Traditional Chinese Medicine, Shenyang, China
The novel oleanolic acid derivative ZQL-4c modulates trastuzumab resistance in HER2+ breast cancer by inhibiting SCD-mediated lipid metabolism disorders
AuthorsYiwen Ma; Shisheng Wang; Xiaorui Li; Xiangyu Guo; Cui Jiang; Tao Sun
Affiliations1. Breast Internal Medicine Ward 1, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, Shenyang, China; 2. Breast Internal Medicine Ward 1, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China; 3. College of Pharmaceutical Science and Technology, Dalian University of Technology, Dalian, China
In silico repurposing of clinically approved drugs as potential BRAF inhibitors: a pharmacophore-based virtual screening and experimental investigation
AuthorsHooriehsadat Amini; Negin Ebrahimi; Sayedali Mousavirahimi; Mozhdeh Zamani; Kowsar Bagherzadeh; Hamed Montazeri; Homa Azizian
Affiliations1. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; 2. Protein Chemistry and Proteomics Laboratory, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran; 3. Student Research Committee, Iran University of Medical Sciences, Tehran, Iran; 4. Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran; 5. Eye Research Center, Five Senses Health Institute, Moheb Kowsar Hospital, Iran University of Medical Sciences, Tehran, Iran; 6. Lyon Cancer Research Center, Centre Léon Bérard, University Claude Bernard Lyon 1, INSERM U1052–CNRS UMR5286, Lyon, France; 7. Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran; 8. Artificial Intelligence in Health Research Institute, Iran University of Medical Sciences, Tehran, Iran; 9. Department of Medicinal Chemistry, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
